[1] |
Gao Zirui, Zhao Pei, Dou Yuanqing, Liu Ping, Zhang Jianzhong.
Efficacy and safety of dupilumab in the treatment of adult prurigo nodularis
[J]. Chinese Journal of Dermatology, 2022, 55(7): 562-565.
|
[2] |
Xu Xiguang, Lu Bin, Sun Jianfang.
A case of X-linked agammaglobulinemia presenting as atopic dermatitis-like lesions
[J]. Chinese Journal of Dermatology, 2022, 55(6): 536-537.
|
[3] |
Lu Xiaoyun, Zhang Zengyunou, Xiao Fengli.
Role of epithelium-derived cytokines interleukin-33, interleukin-25 and thymic stromal lymphopoietin in the pathogenesis of atopic dermatitis
[J]. Chinese Journal of Dermatology, 2022, 55(6): 548-551.
|
[4] |
Working Group for Atopic Dermatitis, Chinese Society of Dermatology, Working Group for Children′s Diseases, Chinese Society of Dermatology.
Treatment of atopic dermatitis with dupilumab: an expert consensus
[J]. Chinese Journal of Dermatology, 2022, 55(6): 465-470.
|
[5] |
Huang Xin, Chen Xiaoyun, Li Yaping, Liang Xingkun, Zhang Guiying, Zhou Ying, Zhan Yi, Luo Shuaihantian, Liao Jieyue, Xiao Rong, Long Hai.
Efficacy and safety of dupilumab in the treatment of 123 cases of atopic dermatitis
[J]. Chinese Journal of Dermatology, 2022, 55(6): 486-493.
|
[6] |
Shen Chen, Tao Juan.
Evolution of assessment of long-term control of and treat-to-target in atopic dermatitis
[J]. Chinese Journal of Dermatology, 2022, 55(5): 442-445.
|
[7] |
Sun Xiaoli, Li Linfeng.
Role of mast cells in the pathogenesis of allergic contact dermatitis
[J]. Chinese Journal of Dermatology, 2022, 55(5): 449-451.
|
[8] |
Yu Su, Yu Tianze, Li Wei.
Role of the autonomic nervous system in immune imbalance in atopic dermatitis
[J]. Chinese Journal of Dermatology, 2022, 55(4): 362-365.
|
[9] |
Qin Shichun, Li Mengjie, Lu Xiaoyun, Xiao Fengli.
Transcriptomics in atopic dermatitis
[J]. Chinese Journal of Dermatology, 2022, 55(4): 365-369.
|
[10] |
Li Wei, Yin Huibin.
Heterogeneity across skin sites in atopic dermatitis
[J]. Chinese Journal of Dermatology, 2022, 55(4): 349-352.
|
[11] |
Li Yan, Li Ming, Xu Wei, Li Linfeng.
Calcium-based antimicrobial peptide compounds cooling gel for the treatment of atopic dermatitis: a randomized, double-blind controlled clinical study
[J]. Chinese Journal of Dermatology, 2022, 55(4): 345-348.
|
[12] |
He Suling, Tian Xin, Liang Jingyao, Shao Lei, Li Junlong, Huang Qiongxiao, Liu Yumei, Wang Jianqin.
Skin microecology in patients with severe atopic dermatitis at acute and remission phases
[J]. Chinese Journal of Dermatology, 2022, 55(4): 329-336.
|
[13] |
Liu Bo, Song Xiaoting, Liao Shuanglu, Yu Miao, Luan Tingting, Li Ruoyu, Zhao Zuotao.
Efficacy and safety of baricitinib in the treatment of moderate-to-severe atopic dermatitis: a clinical observation
[J]. Chinese Journal of Dermatology, 2022, 55(4): 304-307.
|
[14] |
Tian Jing, Liang Yuan, Shen Chunping, Zhao Mutong, Wang Yang, Wang Shan, Jiao Lei, Ma Lin.
Analysis of short-term efficacy and safety of the first subcutaneous injection of dupilumab in the treatment of moderate-to-severe childhood atopic dermatitis
[J]. Chinese Journal of Dermatology, 2022, 55(4): 299-303.
|
[15] |
Liu Bo, Song Xiaoting, Li Ruoyu, Zhao Zuotao.
Clinical efficacy and safety of dupilumab in the treatment of atopic dermatitis
[J]. Chinese Journal of Dermatology, 2022, 55(4): 295-298.
|